Zarbee's Natural Children's Cough + Mucus Syrup Recalled for Storage Temperature Deviations
Family Dollar Stores is recalling Zarbee's Natural Children's Cough + Mucus syrup distributed April through June 2022 due to CGMP violations involving improper storage temperature conditions that may compromise product quality.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class II recall with no reported illnesses, injuries, or deaths. The hazard is a CGMP violation involving improper storage temperature, representing a precautionary recall based on manufacturing standards deviation rather than reported harm.
Plain-English summary
Family Dollar Stores, LLC is recalling Zarbee's Natural Children's Cough + Mucus syrup (4 fl oz bottles, SKU 999983) distributed through specific Family Dollar Store locations from April 30, 2022, through June 10, 2022. The product was held outside appropriate storage temperature conditions, which violates Current Good Manufacturing Practice (CGMP) regulations.
The recalled product was distributed nationwide to Family Dollar Stores. Improper storage temperatures may affect product potency and safety, and the medication's effectiveness cannot be assured. Consumers who purchased this product should stop using it and return it to the point of purchase for a refund or replacement.
The recalled product
- Product
- ZARBEES NTRL CHLD COUGH MUCUS GRP 4 FL OZ distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022.
- Manufacturer
- Family Dollar Stores, Llc.
- Hazard
- improper-storage
- temperature-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- SKU: 999983
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27